BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 21571648)

  • 1. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.
    Lalwani N; Prasad SR; Vikram R; Shanbhogue AK; Huettner PC; Fasih N
    Radiographics; 2011; 31(3):625-46. PubMed ID: 21571648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.
    Ramalingam P
    Oncology (Williston Park); 2016 Feb; 30(2):166-76. PubMed ID: 26892153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.
    Kurman RJ; Shih IeM
    Hum Pathol; 2011 Jul; 42(7):918-31. PubMed ID: 21683865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
    Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
    Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology of epithelial ovarian cancer.
    Christie M; Oehler MK
    J Br Menopause Soc; 2006 Jun; 12(2):57-63. PubMed ID: 16776856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
    Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precursors and pathogenesis of ovarian carcinoma.
    Lim D; Oliva E
    Pathology; 2013 Apr; 45(3):229-42. PubMed ID: 23478230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis in type I epithelial ovarian cancer.
    Sadłecki P; Walentowicz-Sadłecka M; Grabiec M
    Ginekol Pol; 2017; 88(12):692-697. PubMed ID: 29303228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade epithelial ovarian cancer: a number of distinct clinical entities?
    Oswald AJ; Gourley C
    Curr Opin Oncol; 2015 Sep; 27(5):412-9. PubMed ID: 26241347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origins and molecular pathology of ovarian cancer.
    Bell DA
    Mod Pathol; 2005 Feb; 18 Suppl 2():S19-32. PubMed ID: 15761464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
    Kurman RJ; Shih IeM
    Am J Surg Pathol; 2010 Mar; 34(3):433-43. PubMed ID: 20154587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
    Dehari R; Kurman RJ; Logani S; Shih IeM
    Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.
    Kurman RJ
    Ann Oncol; 2013 Dec; 24 Suppl 10():x16-21. PubMed ID: 24265397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian carcinoma: pathology review with an emphasis in their molecular characteristics.
    Lino-Silva LS
    Chin Clin Oncol; 2020 Aug; 9(4):45. PubMed ID: 32434347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data.
    Gilks CB
    Int J Gynecol Pathol; 2004 Jul; 23(3):200-5. PubMed ID: 15213595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade serous ovarian cancer: A review.
    Kaldawy A; Segev Y; Lavie O; Auslender R; Sopik V; Narod SA
    Gynecol Oncol; 2016 Nov; 143(2):433-438. PubMed ID: 27581327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer.
    Fujiwara K; McAlpine JN; Lheureux S; Matsumura N; Oza AM
    Am Soc Clin Oncol Educ Book; 2016; 35():e247-57. PubMed ID: 27249730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.
    Mackenzie R; Talhouk A; Eshragh S; Lau S; Cheung D; Chow C; Le N; Cook LS; Wilkinson N; McDermott J; Singh N; Kommoss F; Pfisterer J; Huntsman DG; Köbel M; Kommoss S; Gilks CB; Anglesio MS
    Am J Surg Pathol; 2015 Nov; 39(11):1548-57. PubMed ID: 26099008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.